Section Arrow
ICAD.NASDAQ
- iCAD
Quotes are at least 15-min delayed:2025/04/30 00:07 EDT
Last
 3.42
+0.09 (+2.70%)
Day High 
3.44 
Prev. Close
3.33 
1-M High
3.38 
Volume 
715.65K 
Bid
3.33
Ask
3.4
Day Low
3.3 
Open
3.3 
1-M Low
1.55 
Market Cap 
91.13M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.93 
20-SMA 2.37 
50-SMA 2.39 
52-W High 3.78 
52-W Low 1.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.21/-0.44
Enterprise Value
91.26M
Balance Sheet
Book Value Per Share
1.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.61M
Operating Revenue Per Share
0.89
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/30 00:07 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging andComputed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.